See more : Schweizerische Nationalbank (0QKG.L) Income Statement Analysis – Financial Results
Complete financial analysis of Day One Biopharmaceuticals, Inc. (DAWN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Day One Biopharmaceuticals, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- NUGL Inc. (NUGL) Income Statement Analysis – Financial Results
- BIGG Digital Assets Inc. (7111.F) Income Statement Analysis – Financial Results
- Shiyue Daotian Group Co., Ltd. (9676.HK) Income Statement Analysis – Financial Results
- Zomato Limited (ZOMATO.NS) Income Statement Analysis – Financial Results
- African Gold Limited (A1G.AX) Income Statement Analysis – Financial Results
Day One Biopharmaceuticals, Inc. (DAWN)
About Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 383.00K | 531.00K | 199.00K | 155.00K | 0.00 |
| Gross Profit | -383.00K | -531.00K | -199.00K | -155.00K | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 130.52M | 85.62M | 43.58M | 9.10M | 13.90M |
| General & Administrative | 75.54M | 61.29M | 29.16M | 4.68M | 1.01M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 75.54M | 61.29M | 29.16M | 4.68M | 1.01M |
| Other Expenses | 1.00 | -18.00K | -15.00K | -31.00K | -2.00K |
| Operating Expenses | 206.06M | 146.91M | 72.74M | 13.78M | 14.91M |
| Cost & Expenses | 206.06M | 146.91M | 72.74M | 13.78M | 14.91M |
| Interest Income | 17.19M | 4.75M | 4.00K | 30.00 | 2.08K |
| Interest Expense | 0.00 | 4.75M | 4.00K | 30.00K | 2.08M |
| Depreciation & Amortization | 383.00K | 531.00K | 199.00K | 155.00K | 14.91M |
| EBITDA | -206.06M | -141.65M | -72.56M | -43.66M | -2.00K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -206.06M | -146.91M | -72.74M | -13.78M | -14.91M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 17.15M | 4.73M | -11.00K | -30.06M | -2.08M |
| Income Before Tax | -188.92M | -142.18M | -72.75M | -43.84M | -16.98M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -10.01M | -2.31M | -3.34M | -2.27M |
| Net Income | -188.92M | -132.18M | -70.44M | -40.51M | -14.71M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -2.37 | -2.02 | -1.14 | -0.65 | -0.24 |
| EPS Diluted | -2.37 | -2.02 | -1.14 | -0.65 | -0.24 |
| Weighted Avg Shares Out | 79.77M | 65.47M | 61.95M | 61.93M | 61.93M |
| Weighted Avg Shares Out (Dil) | 79.77M | 65.47M | 61.95M | 61.93M | 61.93M |
Why Shares of Day One Pharmaceuticals Are Up Monday
Day One has begun a rolling NDA for its candidate DAY101 as a monotherapy for relapsed or progressive pediatric low-grade glioma (pLGG). The company said the drug showed a high overall response rate on heavily pretreated patients with a type...
Day One Biopharmaceuticals shares jump 23% on positive results for glioma treatment
Day One Biopharmaceuticals DAWN, -0.37% shares climbed 23% in premarket trading Monday after the company shared new data on tovorafenib, an investigational treatment for relapsed or progressive pediatric low-grade glioma. Trial data showed high rates of durable tumor reduction and...
Jackson Awards Nearly $700,000 in Grants to Nonprofits Across Lansing, Nashville and Chicago
LANSING, Mich.--(BUSINESS WIRE)--Jackson National Life Insurance Company® (Jackson®), the main operating subsidiary of Jackson Financial Inc.1 (NYSE: JXN), today announced it has awarded nearly $700,000 to nonprofits serving the communities where Jackson has offices: Lansing, Michigan; Nashville, Tennessee; and Chicago,...
Ingenovis Health Unveils Innovative Chief Nurse Advisory Board
GREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)--Ingenovis Health, a leading healthcare talent provider, has announced its new interdisciplinary Chief Nurse Advisory Board (CNAB), designed to leverage collective expertise from across the healthcare industry. The Board’s development comes in response to the ongoing need...
Arizona Center for Civic Leadership Announces 2023 Class of Flinn-Brown Fellows
PHOENIX--(BUSINESS WIRE)--The Arizona Center for Civic Leadership at the Flinn Foundation has selected 28 leaders from across the state as the 15th cohort of Flinn-Brown Fellows. Each brings diverse career and political experiences, policy interests, and perspectives to Arizona’s most...
Colorado School of Mines and Carbon America awarded $32.6M from U.S. Department of Energy CarbonSAFE Initiative
GOLDEN, Colo.--(BUSINESS WIRE)--Colorado School of Mines, Carbon America and Los Alamos National Laboratory (LANL) have been awarded $32.6 million in funding from the U.S. Department of Energy's Carbon Storage Assurance Facility Enterprise (CarbonSAFE) initiative to advance the development of a...
Brandi Carlile, Adam Lambert, Big Freedia, Ciara, Billy Porter, Hayley Kiyoko, Kesha, Kelsea Ballerini and More Join P&G and iHeartMedia’s “Can’t Cancel Pride 2023 – The Future Starts Now” Hosted by JoJo Siwa on June 15
NEW YORK--(BUSINESS WIRE)--This June, Procter & Gamble® (P&G) and iHeartMedia invite people everywhere to join “Can’t Cancel Pride 2023 – The Future Starts Now,” an evening recognizing the LGBTQ+ community and celebrating organizations creating a more inclusive and equal world....
i3forum Launches Consortium Initiative to Restore Trust in International Communications
PARIS--(BUSINESS WIRE)--i3forum, a leading industry association focused on driving global collaboration and innovation within the communications sector, has today launched a new initiative to help restore trust in the international communications industry. The drive towards a consortium model in the...
Lack of Men of Color Graduating From the Health Professions Declared a Crisis by Association CEOs
WASHINGTON--(BUSINESS WIRE)--The Federation of Associations of Schools of the Health Professions (FASHP) has declared the low number of historically underrepresented men of color (HUMOC) graduating and entering the health care professions a national crisis. Representing CEOs of national academic health...
UserTesting’s Milestone 10th Annual Experience Research Industry Report Reveals Organizations Investing More in Customer Experience Research and Insights
SAN FRANCISCO--(BUSINESS WIRE)--UserTesting, a leader in experience research and insights, today released the 2023 Experience Research Industry Report, a compilation of both the UserTesting and UserZoom annual surveys that revealed interest in human insights, also referred to as experience research,...
Source: https://incomestatements.info
Category: Stock Reports